Literature DB >> 6098226

Pharyngoconjunctival fever.

N Giladi, J Herman.   

Abstract

Sixteen infants and toddlers from four kibbutz day nurseries contracted an illness comprising fever, conjunctivitis, respiratory infection, lymphadenopathy, otitis media, and a new sign, migratory palpebral erythema. Adenovirus type 3 was isolated from the pharynx of the first three children taken ill.

Entities:  

Mesh：

Year:  1984        PMID： 6098226      PMCID： PMC1628914          DOI： 10.1136/adc.59.12.1182

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  4 in total

1.  Epidemiology of pharyngoconjunctival fever.

Authors:  J A BELL
Journal:  Am J Ophthalmol       Date:  1957-04       Impact factor: 5.258

2.  Hand-to-hand transmission of rhinovirus colds.

Authors:  J M Gwaltney; P B Moskalski; J O Hendley
Journal:  Ann Intern Med       Date:  1978-04       Impact factor: 25.391

3.  Ocular illness in association with adenovirus type 3 infection. An epidemic of conjunctivitis and keratoconjunctivitis in Stockholm 1969.

Authors:  M Germanis; S Jeansson
Journal:  Scand J Infect Dis       Date:  1973

4.  The Seattle Virus Watch. VII. Observations of adenovirus infections.

Authors:  J P Fox; C E Hall; M K Cooney
Journal:  Am J Epidemiol       Date:  1977-04       Impact factor: 4.897
  4 in total
  3 in total

Review 1.  Genomic foundations of evolution and ocular pathogenesis in human adenovirus species D.

Authors:  Ashrafali Mohamed Ismail; Xiaohong Zhou; David W Dyer; Donald Seto; Jaya Rajaiya; James Chodosh
Journal:  FEBS Lett       Date:  2019-12-11       Impact factor: 4.124

2.  Adenovirus infection in families.

Authors:  O Ruuskanen; J Mertsola; O Meurman
Journal:  Arch Dis Child       Date:  1988-10       Impact factor: 3.791

Review 3.  Pathogenesis and management of adenoviral keratoconjunctivitis.

Authors:  DeGaulle I Chigbu; Bisant A Labib
Journal:  Infect Drug Resist       Date:  2018-07-17       Impact factor: 4.003
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.